Next Article in Journal
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice
Next Article in Special Issue
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults
Previous Article in Journal
COVID-19 Vaccine Hesitancy in China: An Analysis of Reasons through Mixed Methods
Previous Article in Special Issue
Assessment of Reactivity to the Administration of the mRNA Vaccine after Six Months of Observation
 
 
Article

Article Versions Notes

Vaccines 2023, 11(4), 713; https://doi.org/10.3390/vaccines11040713
Action Date Notes Link
article xml file uploaded 23 March 2023 02:05 CET Original file -
article xml uploaded. 23 March 2023 02:05 CET Update -
article pdf uploaded. 23 March 2023 02:05 CET Version of Record -
article html file updated 23 March 2023 02:06 CET Original file -
article xml file uploaded 23 March 2023 08:59 CET Update -
article xml uploaded. 23 March 2023 08:59 CET Update https://www.mdpi.com/2076-393X/11/4/713/xml
article pdf uploaded. 23 March 2023 08:59 CET Updated version of record https://www.mdpi.com/2076-393X/11/4/713/pdf
article html file updated 23 March 2023 09:01 CET Update -
article html file updated 6 April 2023 21:47 CEST Update https://www.mdpi.com/2076-393X/11/4/713/html
Back to TopTop